Long-term function (6 years) of islet allografts in type 1 diabetes

Diabetes

Volumn 46, Issue 12, 1997, Pages 1983-1989

  Alejandro, Rodolfo ^a,b,c   Lehmann, Roger ^a   Ricordi, Camillo ^a,b   Kenyon, Norma S ^a   Angelico, M Clara ^a   Burke, George ^a   Esquenazi, Violet ^a,b   Nery, Jose ^a   Betancourt, Arthur E ^a   Kong, Shen S ^a   Miller, Joshua ^a,b   Mintz, Daniel H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOTRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 14444276779     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.12.1983     Document Type: Article

References (55)

1. Gray DW, McShane P, Grant A, Morris PJ: A method for isolation of islets of Langerhans from the human pancreas. Diabetes 33:1055-1061, 1984
2. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988
3. Scharp DW, Lacy PE, Finke E, Olack B: Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients. Surgery 102:869-879, 1987
4. Rajotte RV, Wamock GL, Evans MG, Ellis D, Dawidson I: Isolation of viable islets of Langerhans from collagenase-perfused canine and human pancreases. Transplant Proc 19:918-922, 1987
5. Alejandro R, Mintz DH, Noel J, Latif Z, Koh N, Russell E, Miller J: Islet cell transplantation in type I diabetes mellitus. Transplant Proc 19:2359-2361, 1987
6. Sutherland DE: Pancreas and islet transplantation. II. Clinical trials (Review). Diabetologia 20:435-450, 1981
7. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, Marchetti P, Gingerich RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW: Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39:515-518,1990
8. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Freschi M, Magistretti P, Socci S, Vignali A, Di Carlo V, Pozza G: Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients: report of six cases. Acta Diabetol 28:151-157,1991
9. Warnock GL, Kneteman NM, Ryan E, Seelis RE, Rabinovitch A, Rajotte RV: Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34:55-58, 1991
10. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV: Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:89-95, 1992
11. Ricordi C, Tzakis AG, Carroll PB, Zeng YJ, Rilo HL, Alejandro R, Shapiro A, Fung JJ, Demetris AJ, Mintz DH, Starzl TE: Human islet isolation and allo-transplantation in 22 consecutive cases. Transplantation 53:407-414, 1992
12. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE: Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341:19-21, 1993
13. Hering BJ, Brendel MD, Schultz AO, Schultz B, Bretzel RG: Newsletter no. 7. International Islet Transplant Registry 6:1-20, 1996
14. Ricordi C: Human islet cell transplantation: new perspectives for an old challenge. Diabetes Rev 4:356-369, 1996
15. Carroll PB, Rilo HL, Alejandro R, Zeng Y, Khan R, Fontes P, Tzakis AG, Carr B, Ricordi C: Long-term (>3-year) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. Transplantation 59:875-879,1995
16. Secchi A, Socci C, Maffi P, Taglietti MV, Falqui L, Bertuzzi F, De Nittis P, Piemonti L, Scopsi L, Di Carlo V, Pozza G: Islet transplantation in IDDM patients. Diabetologia 40:225-232,1997
17. Robertson GS, Chadwick DR, Contractor H, James RF, London NJ: The optimization of large-scale density gradient isolation of human islets. Acta Diabetol 30:93-98, 1993
18. Latif ZA, Noel J, Alejandro R: A simple method of staining fresh and cultured islets. Transplantation 45:827-830, 1988
19. Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R, Zeng Y, Schwarp DW, Viviani G, Falqui L, Tzakis A, Bretzel RG, Federlin K, Pozza G, James RFL, Rajotte RV, Di Carlo V, Morris PJ, Sutherland DER, Starzl TE, Mintz DH, Lacy PE: Islet isolation assessment in man and large animals. Acta Diabetol 27:185-195, 1990
20. Scharp DW, Lacy PE, Weide LG, Marchetti P, McCullough CS, Flavin K, Santiago JV: Intraportal islet allografts: the use of a stimulation index to represent functional results. Transplant Proc 23:796-798,1991 (erratum: Transplant Proc 23:2702, 1991)
21. Angelico MC, Ricordi C, Alejandro R, Albisser AM: Use of an on-line computer system for quantifying insulin requirements before and after islet cell transplantation: first experience. Transplant Proc 27:3173, 1995
22. Albisser AM, Meneghini L, Mintz D: On-line computer system for daily diabetes intervention: first year experience (Abstract). Diabetes 45 (Suppl. 2):71A, 1996
23. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
24. Yang YJ, Youn JH, Bergman RN: Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 253:E595-E602, 1987
25. Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG: Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 97:2611-2618,1996
26. Luzi L, Secchi A, Facchini F, Battezzati A, Staudacher C, Spotti D, Castoldi R, Ferrari G, Di Carlo V, Pozza G: Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 33:549-556, 1990
27. Mintz DH, Alejandro R, Miller J: Human islet transplantation: the University of Miami experience. In Transplantation of the Endocrine Pancreas in Diabeles Mellitus. Van Schilfgaarde R, Hardy MA, Eds. Amsterdam, The Netherlands, Elsevier, 1988, p. 234-239
28. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
29. Christiansen E, Tibell A, Volund A, Groth CG, Hoist JJ, Pedersen O, Christensen NJ, Madsbad S: Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab 81:3972-3985,1996
30. Christiansen E, Andersen HB, Rasmussen K, Christensen NJ, Olgaard K, Kirkegaard P, Tronier B, Volund A, Damsbo P, Burcharth F, Madsbad S: Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Surgery 118:967-972, 1995
31. Tzakis AG, Ricordi C, Alejandro R, Zeng Y, Fung JJ, Todo S, Demetris AJ, Mintz DH, Starzl TE: Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 336:402-405, 1990 (See comments.)
32. Sutherland DE, Goetz FC, Najarian JS: Pancreas transplants from related donors. Transplantation 38:625-633, 1984
33. Weir GC, Bonner-Weir S, Leahy JL: Islet mass and function in diabetes and transplantation. (Review). Diabetes 39:401-405, 1990
34. Weir GC, Bonner-Weir S: Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes (Review). J Clin Invest 85:983-987,1990
35. Nagata M, Mullen Y, Matsuo S, Herrera M, Clare-Salzler M: Destruction of islet isografts by severe nonspecific inflammation. Transplant Proc 22:855-856,1990
36. Brendel MD, Kong SS, Alejandro R, Mintz DH: Improved functional survival of human islets of Langerhans in three-dimensional matrix culture. Cell Transplant 3:427-435,1994
37. Nagata M, Mullen Y, Matsuo S, Wicker LS, Peterson LB: The impact of T cells in nonspecific destruction of beta cells in mice. Transplant Proc 24:988-989, 1992
38. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE: Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary non-function and classic rejection of islet allografts. J Exp Med 172:291-302,1990
39. London NJ, Robertson GS, Chadwick DR, Johnson PR, James RF, Bell PR: Human pancreatic islet isolation and transplantation (Review). Clin Transplant 8:421-459, 1994
40. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341:927-928,1993 (See comments.)
41. Eisenbarth GS, Verge CF, Allen H, Rewers MJ: The design of trials for prevention of IDDM. Diabetes 42:941-947, 1993 (See comments.)
42. Montana E, Bonner-Weir S, Weir GC: Transplanted beta cell response to increased metabolic demand: changes in beta cell replication and mass. J Clin Invest 93:1577-1582,1994
43. Leahy JL: Impaired beta-cell function with chronic hyperglycemia: "overworked beta-cell" hypothesis. Diabetes Rev 4:298-319, 1996
44. Wahoff DC, Papalois BE, Najarian JS, Kendall DM, Farney AC, Leone JP, Jessurun J, Dunn DL, Robertson RP, Sutherland DE: Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 222:562-575,1995
45. Sibley RK, Sutherland DE: Pancreas transplantation: an immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 128:151-170,1987
46. Sutherland DE, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl. 1):85-87, 1989
47. Tyden G, Reinholt FP, Sundkvist G, Bolinder J: Recurrence of autoimmune diabetes mellitus in recipients of cadeveric pancreatic grafts. N Engl J Med 335:860-863, 1996
48. The Diabetes Control and Complications Trial Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-36, 1987
49. Brunicardi FC, Atiya A, Stock P, Kenmochi T, Une S, Benhamou PY, Watt PC, Miyamato M, Wantanabe Y, Nomura Y, Kleinman R, Arita S, Ohtsuka S, Shwvlin I, Rosenthal T, Busuttil RW, Mulien Y, Passara E: Clinical islet transplantation experience of the University of California Islet Transplant Consortium. Surgery 118:967-971, 1995
50. Sjoberg S, Gunnarsson R, Rossner S, Ostman J: Serum lipid and lipoprotein levels in long-term insulin-dependent diabetes mellitus: relation to residual insulin secretion, microvascular lesions and environmental factors. Acta Med Scand 222:445-451, 1987
51. Sjoberg S, Gunnarsson R, Ostman J: Residual C-peptide production in type I diabetes mellitus: a comparison of different methods of assessment and influence on glucose control. Acta Med Scand 214:231-237, 1983
52. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997
53. Kendall DM, Teuscher AU, Robertson RP: Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotrans-plantation in humans. Diabetes 46:23-27, 1997
54. Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, Robertson RP: The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 46:28-33, 1997
55. Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y, Shima K: Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control Diabetes 37:81-88,1988